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cannabis	 use	 and	 dependence	 on	morphology	 of	 the	 hippocampus,	 one	 of	 the	
most	 consistently	 altered	 brain	 regions	 in	 cannabis	 users,	 in	 a	 large	multisite	
dataset	 aggregated	 across	 four	 research	 sites.	 We	 compared	 hippocampal	
volume,	 and	 vertex‐level	 hippocampal	 shape	 differences	 (i)	 between	 121	 non‐
using	 controls	 and	 140	 cannabis	 users;	 (ii)	 between	 106	 controls,	 50	 non‐
dependent	 users,	 and	 70	 dependent	 users;	 and	 (iii)	 between	 a	 subset	 of	 41	
controls,	41	non‐dependent	users,	and	41	dependent	users,	matched	on	sample	
characteristics	and	cannabis	use	pattern	(onset	age	and	dosage).	Cannabis	users	
did	 not	 differ	 from	 controls	 in	 hippocampal	 volume	 or	 shape.	 However,	
cannabis‐dependent	 users	 had	 significantly	 smaller	 right	 and	 left	 hippocampi	
relative	 to	 controls	 and	 non‐dependent	 users,	 irrespective	 of	 cannabis	 dosage.	
Shape	analysis	 indicated	localised	deflations	in	the	superior‐medial	body	of	the	
hippocampus.	 Our	 findings	 support	 neuroscientific	 theories	 postulating	
dependence‐specific	 neuroadaptations	 in	 cannabis	 users.	 Future	 efforts	 should	











most	 recent	 census	estimating	a	prevalence	of	up	 to	183	million	users	 (United	
Nations	Office	on	Drugs	and	Crime	2016).	This	number	may	increase	with	recent	
legislative	changes	and	more	liberal	policies	surrounding	both	recreational	and	
medicinal	 cannabis	 use,	 fueling	 debate	 on	 public	 health	 consequences,	 such	 as	
the	 potential	 increase	 in	 cannabis	 dependence	 and	 cannabis‐related	 problems	
(Hasin,	 Sarvet,	 Cerdá,	 Keyes,	 Stohl,	 Galea	 &	 Wall	 2017).	 Despite	 a	 general	
community	perception	of	harmlessness,	a	subset	of	regular	cannabis	users	–	over	
13	 million	 –	 are	 dependent	 on	 cannabis	 (Degenhardt,	 Ferrari,	 Calabria,	 Hall,	
Norman,	 McGrath,	 Flaxman,	 Engell,	 Freedman,	 Whiteford	 &	 Vos	 2013;	 United	
Nations	Office	on	Drugs	and	Crime	2016).	In	addition,	almost	50%	of	substance	
users	seeking	treatment	are	cannabis	dependent	(United	Nations	Office	on	Drugs	
and	Crime	2016).	Cannabis	dependence	 represents	a	 significant	burden	on	 the	
individual	and	society	but	has	been	poorly	defined	neurobiologically	compared	
to	 heavy,	 non‐dependent	 use.	 This	 warrants	 greater	 attention	 to	 distinctions	
between	 cannabis	 use	 and	 dependence,	 and	 associated	 harms	 and	
vulnerabilities.		
	
Individuals	with	 cannabis	 dependence	 report	 diminished	 control	 over	 use	 and	
compulsive	 use	 despite	 associated	 negative	 consequences	 to	 their	 functioning	
and	 mental	 health	 (American	 Psychiatric	 Association	 2013;	 van	 der	 Pol,	
Liebregts,	De	Graaf,	Ten	Have,	Korf,	Van	den	Brink	&	Van	Laar	2013a).	Relative	
to	non‐dependent	users,	 they	also	experience	greater	mental	health	 issues	 (i.e.	






use	 and	 problem	 use	 (Koenders,	 Cousijn,	 Vingerhoets,	 Van	 Den	 Brink,	 Wiers,	
Meijer,	Machielsen,	Veltman,	Goudriaan	&	De	Haan	2016;	Lorenzetti,	 Solowij	&	
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Yücel	2016c).	In	particular,	the	hippocampus	is	often	suggested	to	be	affected	by	
cannabis	users,	with	 a	number	of	 studies	 reporting	hippocampal	 volume	 to	be	
reduced	 in	 regular	 cannabis	 users	 relative	 to	 non‐users	 (Yücel,	 Solowij,	
Respondek,	 Whittle,	 Fornito,	 Pantelis	 &	 Lubman	 2008;	 Yücel,	 Lorenzetti,	 Suo,	
Zalesky,	 Fornito,	 Takagi,	 Lubman	 &	 Solowij	 2016;	 Demirakca,	 Sartorius,	 Ende,	
Meyer,	 Welzel,	 Skopp,	 Mann	 &	 Hermann	 2011;	 Ashtari,	 Avants,	 Cyckowski,	
Cervellione,	 Roofeh,	 Cook,	 Gee,	 Sevy	 &	 Kumra	 2011;	 Rocchetti,	 Crescini,	
Borgwardt,	 Caverzasi,	 Politi,	 Atakan	&	 Fusar‐Poli	 2013;	 Koenders	 et	al.	 2016).	
However,	 almost	 as	 many	 studies	 have	 not	 observed	 cannabis‐use‐related	
hippocampal	alterations	(Gilman	et	al.,	2014;	Mashhoon	et	al.,	2015;	Medina	et	
al.,	 2007;	 Tzilos	 et	 al.,	 2005;	 Weiland	 et	 al.,	 2015).	 The	 wide‐ranging	 sample	
characteristics	 across	 studies	 (e.g.	 average	 duration	 of	 use	 range	 from	3	 to	 20	
years;	 average	 age	 of	 user	 sample	 range	 from	 20	 to	 40	 years	 old),	 the	 small	
sample	size	of	individual	studies	(i.e.,	range	of	cannabis‐using	sample	from	11	to	
61),	 and	 the	 lack	 of	 consideration	 of	 cannabis	 dependence,	 preclude	
identification	of	key	factors	involved	in	specific	hippocampal	aberrations.		
	






2014)).	 Such	 findings	 may	 reflect	 neural	 adaptations	 that	 discriminate	
compulsive	use	 in	substance	dependence	(Koob	2009;	Chambers	2013;	Koob	&	
Volkow	2017).	However,	most	previous	 studies	of	 regular	 cannabis	users	have	
not	 clarified	 the	 differences	 specific	 to	 dependence	 vs.	 non‐dependence	 in	
regular	 cannabis	 users.	 It	 is	 important	 to	 distinguish	 between	 these	 groups	 to	




the	 hippocampus,	 one	 of	 the	 most	 consistently	 reported	 brain	 regions	 to	 be	
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altered	in	cannabis	users	(Lorenzetti	et	al.	2016c),	by	re‐examining	hippocampal	
morphology	across	an	aggregated	sample	of	261	cannabis	users	(dependent	and	
non‐dependent)	 and	 non‐using	 controls	 from	 four	 research	 sites	 globally	
(Batalla,	Soriano‐mas,	López‐solà,	Torrens,	Crippa,	Bhattacharyya,	Blanco‐hinojo,	
Fagundo,	 Harrison,	 Nogué,	 Torre,	 Farré,	 Pujol	 &	 Martín‐santos	 2013;	 Solowij,	
Walterfang,	 Lubman,	 Whittle,	 Lorenzetti,	 Styner,	 Velakoulis,	 Pantelis	 &	 Yücel	
2013;	 Cousijn,	 Vingerhoets,	 Koenders,	 De	 Haan,	 Van	 Den	 Brink,	 Wiers	 &	
Goudriaan	 2014;	 Yücel	 et	al.	 2016).	 While	 the	 aforementioned	 study	 findings	
have	 been	 mixed	 in	 relation	 to	 hippocampal	 morphology	 in	 diverse	 cannabis	
using	samples,	none	of	these	studies	specifically	examined	cannabis	dependence	
relative	 to	 non‐dependent	 heavy	 use.	 We	 compared	 hippocampal	 morphology	
(i.e.	both	volume	and	shape)	between	(i)	regular	cannabis	users	(CB)	and	non‐
using	 controls	 (CON),	 and	 between	 (ii)	 dependent	 users	 (CB‐dep),	 non‐
dependent	 users	 (CB‐nondep),	 and	 controls	 (CON).	 To	 validate	 potential	
dependence‐related	 hippocampal	 morphological	 differences,	 we	 further	
examined	hippocampal	volume	and	shape	between	(iii)	a	subset	of	CB‐dep,	CB‐
nondep,	and	CON,	matched	on	age,	gender	distribution,	IQ,	and	alcohol	use,	with	
CB‐dep	 and	 CB‐nondep	 further	matched	 on	 tobacco	 use	 and	 cannabis	 use	 (i.e.	








(aged	 18	 to	 56;	 Mdn	 =	 24	 years),	 were	 recruited	 from	 four	 independently	
conducted	studies	across	Amsterdam	(N	=	76;	Cousijn	et	al.,	2014),	Barcelona	(N	
=	 55;	 Batalla	 et	 al.,	 2013),	 Wollongong	 (N	 =	 30;	 Solowij	 et	 al.,	 2013)	 and	
Melbourne	 (N	 =	 100;	 Yücel	 et	 al.,	 2016).	 Inclusion	 and	 exclusion	 criteria	 have	
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use	 for	 a	 considerable	 period	 of	 time	 (duration	 of	 regular	 use,	Mdn	 =	 6	 years,	
range	=	0.5	–	38	years;	lifetime	use,	Mdn	=	15690	cones,	range	=	600	–	864000	
cones).	Meanwhile,	CON	used	less	than	50	times	in	their	lifetime	and	did	not	use	
in	 the	 past	 month.	 All	 subjects	 had	 no	 history	 of	 chronic	 medical	 illness	 or	





Participants’	 demographic	 and	 substance	 use	 characteristics	 were	 assessed	
separately	 at	 each	 individual	 research	 site.	 Select	 information	 (i.e.	 age,	 gender,	
IQ,	 monthly	 tobacco	 (cigarettes)	 use,	 monthly	 standard	 alcoholic	 drinks,	 and	
cannabis	 use	 measures)	 was	 subsequently	 standardised	 across	 sites	 (see	
measures	in	Supplementary	Table	S1).	Cannabis	use	measures	included	monthly	





and	was	used	 to	 separate	 the	aggregated	 three‐site	 sample	 into	70	CB‐dep,	50	
CB‐nondep,	 and	 106	 CON	 based	 on	 recommended	 norms,	 and	 after	 excluding	
subjects	 with	missing	 dependence	 information.	 Specifically,	 in	 Amsterdam	 the	
Mini	 International	 Neuropsychiatric	 Interview’s	 (MINI)	 ‘non‐alcohol	
psychoactive	substance	use	disorders’	module	was	used,	with	a	cut‐off	of	3	and	
above	as	CB‐dep	(Lecrubier,	Sheehan,	Weiller,	Amorim,	Bonora,	Sheehan,	Janavs	






site.	 Scanner	 details	 have	 been	 documented	 previously	 (Batalla	 et	 al.	 2013;	
Solowij	et	al.	2013;	Cousijn	et	al.	2014;	Yücel	et	al.	2016;	Chye	et	al.	2017a),	as	
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MR	 images	 were	 corrected	 for	 intensity	 inhomogeneity	 –	 nonparametric	
nonuniform	 intensity	 normalisation	 (N3;	 Sled,	 Zijdenbos	 &	 Evans	 1998)	 using	
FreeSurfer	 image	 analysis	 (http://surfer.nmr.mgh.harvard.edu/)	 version	 5.3.0.	
An	estimate	of	the	intracranial	volume	(ICV)	was	also	obtained	from	FreeSurfer’s	
automated	 parcellation	 procedure.	 Subsequently,	 the	 images’	 intensity	 was	
standardised	across	sites,	based	on	 the	average	grey	matter,	white	matter,	and	
cerebrospinal	 fluid	 intensity	 from	each	 site,	 using	 the	FMRIB	 Software	 Library	
(FSL;	 http://www.fmrib.ox.ac.uk/fsl/).	 Finally,	 the	 images	 were	 visually	




The	 hippocampus	 was	 manually	 traced	 by	 a	 trained	 tracer	 (Y.C.)	 blinded	 to	
group	 and	 site	 membership,	 using	 the	 Analyze	 12.0	 software	 (AnalyzeDirect,	
Overland	 Park,	 KS),	 according	 to	 a	 validated	 protocol	 (Velakoulis,	 Pantelis,	
McGorry,	 Dudgeon,	 Brewer,	 Cook,	 Desmond,	 Bridle,	 Tierney,	 Murrie,	 Singh	 &	
Copolov	 1999).	 Hippocampal	 boundaries	were	 defined	 posteriorly	 as	 the	 slice	
with	 the	 greatest	 length	 of	 continuous	 fornix;	medially	 as	 the	 open	 end	 of	 the	
hippocampal	fissure	(posterior)	and	the	uncal	fissure	(anterior);	laterally	as	the	
temporal	horn	of	 the	 lateral	ventricle;	 inferiorly	as	 the	parahippocampal	white	
matter;	 and	 superiorly	 as	 the	 fimbria	 and	 alveus	 (posterior)	 as	 well	 as	 the	
amygdala	(anterior).		
	
Intra‐	 and	 inter‐rater	 reliabilities	 (i.e.	 Intraclass	 Correlation	 Coefficient	 (ICC),	
absolute	agreement,	single	measures)	for	the	hippocampal	tracing	were	assessed	
on	 28	 randomly	 selected	 images.	 Intra‐rater	 reliabilities	 for	 the	 right	 and	 left	
hippocampus	were	.97	and	.88	respectively,	while	inter‐rater	reliabilities	against	
an	expert	 tracer	 (V.L.)	were	 .90	and	 .93	respectively.	 Intra‐rater	reliability	was	
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also	consistent	across	scanner	 field	 strength,	at	an	 ICC	of	 .95	 (collapsed	across	
both	hemispheres)	 for	both	1.5T	and	3T	scanners.	As	 tracing	of	all	261	 images	
proceeded	 over	 a	 four‐month	 period	 (from	 April	 2016	 to	 August	 2016),	
longitudinal	 intra‐rater	 reliability	 was	 performed	 on	 15	 images	 (i.e.	 5	 images	
repeated	3	times,	evenly	distributed	across	the	blinded	sample).	Values	were	.93	
and	 .83	 for	 the	 right	 and	 left	 hippocampus	 respectively,	 indicating	 good	
consistency	over	time.	
	
A	 series	 of	 univariate	 analysis	 of	 covariance	 (ANCOVA)	 models	 were	 run	 to	




CB‐nondep,	 and	 CB‐dep	 (only	 from	 the	 three	 sites	 that	 obtained	 dependence	
measures	 –	 Amsterdam,	 Barcelona,	 Melbourne),	 controlling	 for	 all	 previously	
mentioned	 variables;	 (iib)	 comparison	 between	 CB‐nondep	 and	 CB‐dep	 users	
only,	 with	 additional	 inclusion	 of	 all	 cannabis	 use	measures	 (current	monthly	
cones,	lifetime	cones	and	age	of	regular	use)	as	covariates;	and	(iii)	comparison	
between	 CON,	 CB‐nondep,	 and	 CB‐dep,	 in	 a	 subset	 of	 subjects	 matched	 on	
gender,	age,	 IQ,	and	alcohol	use	across	all	groups,	and	matched	on	tobacco	and	




The	manually‐traced	 hippocampal	 boundaries	 (i.e.,	 object	maps)	were	 used	 to	
run	 shape	 analysis	 within	 FSL.	 First,	 the	 object	 maps	 were	 registered	 to	 MNI	




voxel	 thick	 average	boundary	 shape	by	 subtracting	away	 an	 eroded	version	of	
the	threshold‐shape.	The	signed	distance	of	each	individual	hippocampal	object	
to	every	point	on	 the	average	boundary	shape	could	 then	be	calculated.	A	 flow	
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analysis.	 A	 permutation‐based	 approach	 with	 threshold‐free	 cluster	
enhancement	(TFCE)	was	adopted	using	FSL’s	Randomise	tool	(Smith	&	Nichols	
2009;	 Winkler,	 Ridgway,	 Webster,	 Smith	 &	 Nichols	 2014).	 A	 total	 of	 100,000	
permutations	were	used	 for	 the	analysis,	examining	shape	differences	between	
(i)	CON	versus	CB,	and	 (ii)	CON	versus	CB‐nondep	versus	CB‐dep,	and	 (iii)	 the	




Given	 that	 it	 is	 often	 unfeasible	 for	 all	 studies,	 particularly	 studies	 with	 large	
databases,	to	quantify	brain	structures	via	manual	tracing,	we	further	compared	
the	 performance	 of	 the	 automated	 tool	 –	 FreeSurfer	 in	 hippocampal	
segmentation,	 by	 replicating	 all	 volume	 and	 shape	 analysis.	 Hippocampal	
segmentation	was	performed	by	FreeSurfer	version	5.3,	as	described	by	Fischl,	
Salat,	 Busa,	 Albert,	 Dieterich,	 Haselgrove,	 van	 der	 Kouwe,	 Killiany,	 Kennedy,	
Klaveness,	 Montillo,	 Makris,	 Rosen	 &	 Dale	 (2002).	 Shape	 analysis	 was	 also	
performed	with	a	similar	processing	step	as	presented	in	Supplementary	Fig.	S1.	
The	automated	segmentation	procedure	was	also	validated	against	our	manual	
tracing,	 which	 is	 considered	 the	 gold	 standard	 for	 evaluating	 hippocampal	
volume	 (Velakoulis	et	al.	 1999),	by	examining	 the	 (i)	 correlation	between	both	
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Participant	 characteristics	 and	 hippocampal	 volume	 measures	 (i)	 by	 cannabis	
use	(i.e.	CON	vs.	CB)	and	(ii)	by	cannabis	dependence	(i.e.	CON	vs.	CB‐nondep	vs.	
CB‐dep),	 are	presented	 in	Tables	1	 and	2	 respectively.	The	 separate	data	 from	
each	imaging	site	are	presented	in	Supplementary	Tables	S2	and	S3.		
	
A	 subset	 of	 matched	 CON,	 CB‐nondep,	 and	 CB‐dep	 were	 selected,	 to	 verify	
volumetric	 findings.	 CB‐nondep	 and	 CB‐dep	 were	 matched	 on	 age,	 gender,	 IQ	






	 ̅ . .⁄ 	
	
where	 v	 =	 the	 variables:	 age,	 IQ,	 alcohol,	 tobacco,	 cannabis	 onset,	 cannabis	
monthly	 use,	 and	 cannabis	 lifetime	 use.	 Cannabis‐using	 subjects	 were	 ranked	




regards	 to	 age,	 IQ,	 alcohol,	 and	 tobacco	 use.	 Nevertheless,	 we	 were	 unable	 to	
match	CON	to	CB‐nondep	and	CB‐dep	on	tobacco	use,	 from	the	Melbourne	site.	




CON	 and	 CB	 did	 not	 differ	 significantly	 in	 right	 or	 left	 hippocampal	 volume	
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site	 effect	 was	 also	 found	 (F3,250	 =	 12.34	 and	 10.65	 for	 the	 right	 and	 left	
hippocampus	respectively,	p	<	.001,	ηp2	≥	.129),	with	participants	from	Barcelona	
demonstrating	smaller	hippocampi	 than	participants	 from	every	other	site	(p	≤	
.006)	 while	 participants	 from	 Amsterdam	 had	 larger	 hippocampi	 than	
participants	 from	 Melbourne	 (p	 ≤	 .018).	 IQ	 significantly	 affected	 left	






significant	effect	 of	dependence	group	 in	 the	 right	 (F2,215	 =	5.91,	p	=	 .003,	ηp2	=	
.052,	medium	effect	size)	and	left	(F2,215	=	4.49,	p	=	.012,	ηp2	=	.040,	medium	effect	





Females	 had	 smaller	 hippocampi	 than	 males,	 and	 again	 participants	 from	 the	
Barcelona	site	had	smaller	hippocampi	than	those	from	the	other	two	sites	(p	≤	
.001),	while	participants	 from	 the	Amsterdam	site	had	 larger	hippocampi	 than	
those	 from	 Melbourne	 (p	 ≤	 .026).	 None	 of	 the	 covariates	 were	 statistically	
significant	in	the	model	(p	≥	.087,	ηp2	≤	.014).	
	
To	 establish	 the	 specificity	 of	 volumetric	 differences	 to	 cannabis	 dependence	
rather	 than	 cannabis	 use	 or	 exposure	 (and	 particularly	 since	 CB‐dep	 had	
significantly	greater	monthly	use	than	CB‐nondep),	CB‐dep	and	CB‐nondep	were	
further	 compared,	 additionally	 controlling	 for	 cannabis	 use	measures	 (current	
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ηp2	=	 .055,	medium	effect	size)	and	left	hippocampi	(F1,104	=	6.19,	p	=	 .014,	ηp2	=	
.056,	medium	 effect	 size)	 than	 CB‐nondep	 after	 controlling	 for	 these	 cannabis	
use	measures.	
	





we	 were	 unable	 to	 match	 tobacco	 use.	 Furthermore,	 CB‐nondep	 and	 CB‐dep	
were	matched	on	all	previously	mentioned	variables	(i.e.	gender,	age,	IQ,	alcohol,	
and	tobacco	use),	and	cannabis	use	pattern.	The	effect	of	cannabis	dependence	
persisted	 for	 the	 right	 (F1,112	 =	 3.97,	 p	 =	 .022,	 ηp2	=	 .066)	 and	 left	 hippocampi	






Cluster‐based	 shape	 analysis	 was	 performed	 controlling	 for	 ICV,	 imaging	 site,	
gender,	 IQ,	age,	alcohol	use	and	 tobacco	use.	Comparison	between	(i)	CON	and	
CB	 revealed	 no	 significant	 shape	 difference	 between	 groups.	 However,	
comparison	 between	 (ii)	 CON,	 CB‐nondep,	 and	 CB‐dep	 demonstrated	 a	
significant	shape	difference	between	CB‐nondep	and	CB‐dep	in	the	right	and	left	
hippocampus	(Fig.	2A‐D),	but	not	between	CON	and	CB‐nondep,	or	CON	and	CB‐
dep§.	 Specifically,	 deflation	 occurred	 along	 the	 superior‐medial	 body	 of	 the	
hippocampi	 of	 CB‐dep	 relative	 to	 CB‐nondep.	 Nevertheless,	 when	 comparison	
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Hippocampal	volume	and	shape	‐	FreeSurfer	vs.	manual	tracing	
All	 hippocampal	 volume	 and	 shape	 analyses	 were	 replicated	 using	 the	
automated	segmentation	software	FreeSurfer.	FreeSurfer	performance	was	also	
validated,	relative	to	manual	tracing,	by	examining	the	correlation	between	both	
methods,	 and	 the	 percent	 volume	 overlap.	 Results	 for	 FreeSurfer‐segmented	
hippocampal	comparison	between	(i)	CON	and	CB,	(iia)	CON,	CB‐nondep	and	CB‐
dep,	 (iib)	 CB‐nondep	 and	 CB‐dep	 only,	 and	 (iii)	 matched	 subset	 of	 CON,	 CB‐
nondep,	and	CB‐dep	are	presented	in	Supplementary	Table	5.	Briefly,	there	was	
no	significant	hippocampal	volume	difference	between	CON	and	CB,	but	CB‐dep	
users	 similarly	 showed	 a	 larger	 left	 hippocampus	 than	 CB‐nondep	 users	 (p	 =	
.013).	 When	 only	 CB‐nondep	 and	 CB‐dep	 users	 were	 compared,	 additionally	
controlling	 for	 cannabis	 use	 pattern,	 CB‐dep	 users	 again	 demonstrated	
significantly	 larger	 right	 and	 left	 hippocampi	 relative	 to	 CB‐nondep	 users	 (p	 =	
.027	and	p	=	 .005	 respectively).	When	 the	matched	subset	of	CON,	CB‐nondep,	
and	 CB‐dep	 were	 compared	 however,	 no	 significant	 dependence	 effect	 was	
found.	 Cluster‐based	 shape	 analysis	 of	 FreeSurfer‐segmented	 hippocampi	
meanwhile	 only	 demonstrated	 a	 shape	 difference	 between	 CB‐dep	 and	 CB‐
nondep	 users	 that	 did	 not	 survive	 FWE‐correction.	 While	 the	 FreeSurfer	
segmented	 hippocampi	 were	 strongly	 correlated	 with	 the	 manual	 tracing	
(R=0.72	and	0.66	for	the	right	and	left	hippocampus	respectively,	p	<	 .001),	the	
FreeSurfer	 hippocampi	 are	 systematically	 larger	 than	 the	 manual	 output,	 as	
illustrated	 in	 the	 Bland‐Altman	 plot	 (Supplementary	 Fig.	 S3).	 Estimation	 of	
volume	overlap	between	both	methods	 suggests	 an	average	volume	overlap	of	
71.2%	 (SD	 =	 4.39%)	 and	 70.10%	 (SD	 =	 4.75%)	 for	 the	 right	 and	 left	






In	 this	 large‐scale	 multi‐site	 study,	 we	 demonstrated	 significant	 hippocampal	
volume	 reduction	 only	 in	 cannabis	 dependent	 users	 relative	 to	 both	 non‐user	
controls	and	non‐dependent	users,	irrespective	of	extent	of	cannabis	use.	Shape	
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difference	 was	 also	 observed	 in	 the	 right	 and	 left	 hippocampus,	 only	 in	
dependent	 users	 (deflation	 of	 the	 superior‐medial	 body)	 relative	 to	 non‐
dependent	 users.	 These	 results	 suggest	 that	 hippocampal	 volume	 and	 shape	
alterations	may	be	specific	to	cannabis	dependence	rather	than	non‐dependent	
regular	cannabis	use.	Our	findings	are	consistent	with	previous	work	reflecting	
dependence‐specific	 effects,	 for	 example	 in	 neuroanatomical	 and	 functional	
alteration	across	the	cortical	and	limbic	regions	(Filbey	&	Dunlop	2014;	Chye	et	
al.	2017b	a).	Future	investigative	efforts	should	thus	be	mindful	in	assessing	and	
discriminating	 between	 cannabis	 use	 and	 dependence	 when	 evaluating	 the	
harms	and	vulnerabilities	associated	with	chronic	cannabis	use.	
	
Hippocampal	 volumetric	 reduction	 is	 the	 most	 consistently	 reported	
neuroanatomical	 finding	 in	 regular	 cannabis	 users	 relative	 to	 non‐users	








hippocampal	morphology	 to	be	dissociated	 from	those	due	 to	 level	of	cannabis	
use.	 This	 contrasts	 previous	 reports	 of	 a	 dose‐dependent	 association	 between	
hippocampal	volume	and	cannabis	dosage	(Yücel	et	al.	2008;	Ashtari	et	al.	2011;	
Cousijn,	Wiers,	Ridderinkhof,	Brink,	Veltman	&	Goudriaan	2012).	However,	none	
of	 the	 aforementioned	 studies	 discriminated	 between	 dependent	 and	 non‐
dependent	 users	 in	 their	 samples,	 and	might	 not	 have	 been	 able	 to	 dissociate	
hippocampal	differences	 linked	to	dosage	versus	dependence.	 Indeed,	 less	than	
40%	of	 frequent	 cannabis	 users	 (i.e.	 using	≥3	 days	 per	week	 for	 ≥1	 year)	will	










We	 also	 found	 a	 localised	 shape	 difference	 between	 dependent	 and	 non‐
dependent	 users	 along	 the	 superior‐medial	 body	 of	 the	 hippocampus,	 roughly	




in	 the	 original	 analysis,	 to	 123	 in	 this	 analysis)	 resulted	 in	 reduced	 power	 to	
detect	 subtle	 shape	 effects.	 Hippocampal	 shape	 alterations	 in	 cannabis	 users	
have	 only	 been	 examined	 in	 four	 prior	 studies,	 demonstrating	 regional	 shape	
differences	 in	 current	 users,	 recreational	 users	 (Mdn	 =	 6‐10	 lifetime	 use),	 and	
users	with	a	past	cannabis	use	disorder	(Solowij	et	al.	2013;	Smith,	Cobia,	Reilly,	
Gilman,	 Roberts,	 Alpert,	 Wang,	 Breiter	 &	 Csernansky	 2015;	 Orr,	 Paschall	 &	
Banich	 2016;	 Koenders,	 Lorenzetti,	 Haan,	 Suo,	 Vingerhoets,	 Van	 den	 Brink,	
Wiers,	 Meijer,	 Machielsen,	 Goudriaan,	 Veltman,	 Yücel	 &	 Cousijn	 2017).	 Our	
finding	is	consistent	with	previous	reported	alterations	in	regular	cannabis	users	
(i.e.	 shape	deflation	along	 the	hippocampal	head	and	body	(Solowij	et	al.	2013;	
Koenders	 et	al.	 2017))	 and	 in	 dependent	 users	 (i.e.,	 reduced	 CA3	 and	CA4/DG	
volume	 (Chye	 et	 al.	 2017b)).	 Deflation	 confined	 to	 the	 CA3	 and	 CA4/DG	
hippocampal	 subregions	 is	 noteworthy	 as	 these	 are	 the	 major	 sites	 for	 adult	
neurogenesis	and	subsequent	innervation	of	new	neurons,	a	process	crucial	for	
learning	and	memory,	as	well	 as	affective	and	stress	 regulation	 (Canales	2007;	
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Morales	 2015).	 Our	 finding	 of	 hippocampal	 alteration	 specific	 to	 cannabis	
dependence	supports	theories	suggesting	dependence‐specific	neuroalterations.	
The	amygdala‐hippocampal	system	is	involved	in	affective	processing	(Ekhtiari,	
Victor	 &	 Paulus	 2017),	 with	 impaired	 hippocampal	 functioning	 (e.g.	 low	




use	 (Stewart	 2003;	 Koob	 2009;	 van	 der	 Pol	 et	 al.	 2013c).	 Additionally,	
hippocampal	function	is	also	necessary	to	guide	learning	and	adaptive	behavior,	
with	 impaired	 function	 suggested	 to	 restrict	 the	 complexity	 and	 flexibility	 of	
motivational	 learning	 that	 subserves	 the	 extinction	 of	 substance	 use	 behavior,	
thus	contributing	 to	 the	maintenance	of	dependence	(Canales	2007;	Chambers,	
Bickel	&	Potenza	2007;	Redish	et	al.	2008;	Chambers	2013).	While	future	efforts	
are	 necessary	 to	 expand	 on	 the	 link	 between	 hippocampal	 neuroanatomy	 and	
the	 cognitive,	 stress,	 and	 affective	 regulation	 process	 guiding	 cannabis	
dependence,	 it	 nonetheless	 appears	 that	 dependent	 cannabis	 users	 may	 be	
distinctly	 impacted	 in	 neuroanatomy	 (Filbey	 &	 Yezhuvath	 2013;	 Chye	 et	 al.	
2017b	a).		
	
Finally,	 we	 compared	 the	 consistency	 between	 two	 separate	 methods	 of	
measuring	hippocampal	volumes	 i.e.	 FreeSurfer	and	manual	 segmentation	 (see	
Supplementary	Material	2),	and	showed	that	these	were	highly	correlated	(about	
70%	 volume	 overlap).	 FreeSurfer	 produced	 systematically	 larger	 hippocampi	
than	 did	 manual	 segmentation,	 which	 may	 be	 due	 to	 its	 greater	 tendency	 to	
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cannabis	 use	 pattern,	 but	 not	 in	 the	matched	 subset	 analyses,	 Supplementary	
Table	S5),	suggesting	mostly	consistent	results	from	both	methods.	The	manual	
segmentation	 method	 is	 considered	 the	 gold	 standard	 for	 evaluating	
hippocampal	 volume	 (Velakoulis	 et	al.	 1999),	 and	 assumed	 to	 be	 superior	 to	
automated	 methods	 (i.e.	 SPM,	 FSL,	 FreeSurfer),	 as	 it	 allows	 for	 a	 more	 fine‐
grained	 inspection	 of	 hippocampal	 volume	 and	 shape.	Meanwhile	 FreeSurfer’s	
estimations	of	hippocampal	volume	tend	to	show	a	larger	variance,	in	addition	to	
a	tendency	to	underestimate	grey	matter	volume	with	increasing	scanner	noise,	
causing	 it’s	 output	 to	 be	 more	 subject	 to	 hardware‐related	 differences	 (Butts	
2013;	 Wenger,	 Mårtensson,	 Noack,	 Bodammer,	 Kühn,	 Schaefer,	 Heinze,	 Düzel,	
Bäckman,	 Lindenberger	 &	 Lövdén	 2014;	 Fellhauer,	 Zöllner,	 Schröder,	 Degen,	
Kong,	Essig,	Thomann	&	Schad	2015).	As	 such,	when	assessing	 impacts	on	 the	














compare	 levels	 of	 dependence	 severity	 with	 hippocampal	 morphology	 across	
sites	 or	 examine	 severity	 in	 regression	models.	 Instead,	 we	 adopted	 validated	
cut‐offs	 (Lecrubier	 et	 al.	 1997;	 Swift,	 Copeland	 &	 Hall	 1998;	 van	 der	 Pol,	
Liebregts,	 de	 Graaf,	 Korf,	 van	 den	 Brink	 &	 van	 Laar	 2013b)	 to	 consistently	
investigate	 hippocampal	 morphology	 between	 dependent	 and	 non‐dependent	
users.	 Studies	 using	 consistent	 diagnostic	 instruments	 of	 substance	 use	
disorders	 (e.g.	 DSM‐5;	 American	 Psychiatric	 Association	 2013)	 are	 needed	 to	
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verify	 the	 association	 between	 hippocampal	 morphology	 and	 dependence	
severity,	 particularly	 in	 further	 delineating	 the	 relationship	 between	
dependence,	 cognitive	 and	 affective	 regulation,	 and	 the	 neuroanatomy	 of	
substance	 users	 (Lorenzetti,	 Cousijn,	 Solowij,	 Garavan,	 Suo	 &	 Verdejo‐García	
2016a;	 Lorenzetti,	 Solowij,	 Suo,	 Walterfang,	 Lubman,	 Verdejo‐García,	 Cousijn,	




We	 extend	 on	 previous	 studies	 of	 hippocampal	 morphological	 alteration	 (i.e.	
shape	and	volume)	 in	non‐dependent	and	dependent	 cannabis	users	 in	a	 large	
multisite‐imaging	 cohort,	 using	 both	 manual	 tracing	 and	 automated	 methods.	
Hippocampal	 volume	 reduction	 was	 specific	 to	 dependent	 users,	 even	 after	
controlling	 for	 cannabis	 dosage	 and	 sample	 characteristic	 (i.e.	 age,	 IQ,	 alcohol	
and	 tobacco	 use).	 There	 was	 also	 an	 emerging	 shape	 difference	 along	 the	
superior‐medial	 boundary	 of	 the	 hippocampus,	 between	 dependent	 and	 non‐
dependent	users.	Our	findings	suggest	that	not	all	cannabis	users	are	alike,	with	
a	 sub‐group	 of	 vulnerable	 users	 –	 dependent	 users	 –	 showing	 hippocampal	
morphological	 alterations	 compared	 to	 non‐dependent	 users	 and	 controls.	
Further	 steps	 should	 be	 made	 to	 characterise	 and	 verify	 the	 neural	 and	
behavioral	 differences	 that	 separate	 non‐dependent	 and	 dependent	 cannabis	
users	in	large	normative	samples	and	treatment	seeking	populations,	whether	as	
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Age	(years)	 26.12	(9.03)	 28.03	(10.25)	 1.58	
Gender	(%	M	/	F)	 70.25	/	29.75	 67.14	/	32.86	 0.29	
IQ	a	 109.31	(10.54)	 103.45	(10.74)		 4.44***
Alcohol	(StDr/mth)	b	 19.87	(23.77)	 24.43	(25.18)	 1.50	
Tobacco	(Cig/mth)	b	 30.88	(97.92)	 254.96	(233.77)	 9.82***
Cannabis	Use	 	 	 		




					Lifetime	Use	(cones)	 ‐	 57,107	(99,987)	 ‐	
Volumetric	measures	(mm3)	 	 	 	
Intracranial	Volume	(106)	 1.55	(0.20)	 1.52	(0.17)	 1.31	
Right	hippocampus	 	 	 	
					Manual	 2,584.45	(362.77)	 2,411.68	(316.24)	 2.50d	
					FreeSurfer	c	 4,509.66	(469.21)	 4,381.56	(414.04)	 0.00d	
Left	hippocampus	 	 	 	
					Manual	 2,455.05	(342.42)	 2,314.68	(307.18)	 1.56d	
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Table	2	Sample	characteristics	and	MR	volumetric	measures	of	controls	(CON),	









Age	(years)	 24.77	(7.91)	 27.07	(10.33)	 26.74	(9.18)	 1.61	
Gender	(%	M	/	F)	 66.98	/	33.02	 60.00	/	40.00	 64.29	/	35.71	 0.73	
IQ	a	 108.65	(10.71)	 103.03	(11.13)	 102.13	(10.86)	 9.15***d	






Cannabis	Use	 	 	 	 		














Intracranial	Volume	(106)	 1.53	(0.19)	 1.46	(0.19)	 1.53	(0.15)	 2.72	




























































Age	(years)	 26.09	(8.68)	 28.58	(10.81)	 26.71	(8.54)	 0.79	
Gender	(%	M	/	F)	 63.4	/	36.6	 63.4	/	36.6	 63.4	/	36.6	 0.00	
IQ	a	 107.35	(8.87)	 103.33	(12.11)	 103.92	(8.78)		 1.92	
Alcohol	(StDr/mth)	b	 24.39	(27.15)	 20.65	(22.84)	 20.52	(17.22)	 0.38	
Tobacco	(Cig/mth)	b	 76.28	(143.36)		 238.83	(253.82) 213.64	(187.22) 7.84**	c	
Cannabis	Use	 	 	 	 		
					Age	of	Regular	Use	 ‐	 17.82	(2.81)	 17.48	(2.58)		 0.57	
					Current	Use	
					(cones/month)	
‐	 235.40	(209.86) 278.94	(172.76) 1.03	
					Lifetime	Use	(cones)	 ‐	 38,340	(50,702) 37,288	(45,640) 0.10	
Volumetric	measures	(mm3)	 	
Intracranial	Volume	(106)	 1.54	(0.17)	 1.49	(0.18)	 1.50	(0.17)	 0.40	
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d	F	statistic	for	group	comparison	of	hippocampal	volume,	controlling	for	imaging	site	as	random	









nondep)	 and	 dependent	 (CB‐dep)	 cannabis	 users,	 corrected	 for	 intracranial	
volume	(ICV)	and	gender;	bars	represent	95%	confidence	interval;	*p	<	.05	**p	<	
.01.	
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